Neurocrine Biosciences Inc.
NBIX | NASDAQ
$145.89
-$0.21 (-0.14%)
Nov 2, 2026, 2:12 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 959M | 814.5M | 805.5M | 794.9M | 687.5M | 572.6M | 627.7M | 622.1M | 590.2M | 515.3M | 515.2M | 498.8M | 452.7M | 420.4M | 412M | 387.9M | 378.2M | 310.6M | 312M | 296M | 288.9M | 236.6M |
Cost of Revenue | 23.2M | 13.8M | 17.6M | 14M | 11.3M | 9.2M | 9.3M | 8M | 9.2M | 7.5M | 8.5M | 11.2M | 11.5M | 8.5M | 7.7M | 6.1M | 4.8M | 4.6M | 4.1M | 4.2M | 3.1M | 2.9M |
Gross Profit | 935.8M | 800.7M | 787.9M | 780.9M | 676.2M | 563.4M | 618.4M | 614.1M | 581M | 507.8M | 506.7M | 487.6M | 441.2M | 411.9M | 404.3M | 381.8M | 373.4M | 306M | 307.9M | 291.8M | 285.8M | 233.7M |
Operating Income | 153M | 186M | 210.9M | 239M | 145.6M | 23.6M | 142M | 183.8M | 145.4M | 99.3M | 150.3M | 141.2M | 73.6M | -114.2M | 103.4M | 87.8M | 54.7M | 3.1M | -36.3M | 44.5M | 62.8M | 31.5M |
Interest Income | n/a | 28.1M | -42.8M | 22.2M | 20.6M | 21.7M | n/a | n/a | n/a | n/a | n/a | n/a | 12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 162.2M | 246.8M | 239.4M | 291.8M | 159.5M | 14.7M | 162.6M | 190.3M | 98.6M | 34.5M | 198.2M | 115.6M | 121.6M | -103.3M | 117.9M | 97.9M | -23.3M | 21.4M | -13.8M | 30.5M | 57.5M | 27.2M |
Net Income | 144.4M | 197.9M | 153.7M | 209.5M | 107.5M | 7.9M | 103.1M | 129.8M | 65M | 43.4M | 147.7M | 83.1M | 95.5M | -76.6M | 89M | 68.5M | -16.9M | 13.9M | -7.3M | 22.5M | 42.3M | 32.1M |
Selling & General & Admin | 439.7M | 318.5M | 301.8M | 291.6M | 286.3M | 276.5M | 287.8M | 234.3M | 242M | 243.1M | 218.9M | 204.2M | 221.8M | 242.7M | 182.9M | 186.3M | 182.8M | 200.7M | 156.5M | 154.6M | 143.2M | 129M |
Research & Development | 326.7M | 296.2M | 258.2M | 250M | 244.3M | 263.2M | 185.6M | 195M | 191.1M | 159.4M | 137.5M | 142.2M | 145.8M | 139.5M | 118M | 107.7M | 135.9M | 102.2M | 87.4M | 92.7M | 74.8M | 73.2M |
Other Expenses | 16.4M | n/a | 17M | 300K | n/a | 100K | 3M | 1M | 2.5M | 6M | n/a | n/a | n/a | 143.9M | n/a | n/a | n/a | n/a | 100.3M | n/a | 5M | n/a |
Operating Expenses | 782.8M | 614.7M | 577M | 541.9M | 530.6M | 539.8M | 476.4M | 430.3M | 435.6M | 408.5M | 356.4M | 346.4M | 367.6M | 526.1M | 300.9M | 294M | 318.7M | 302.9M | 344.2M | 247.3M | 223M | 202.2M |
Interest Expense | 2.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 49.7M | 1.1M | 1.1M | 1.1M | 1.3M | 1.1M | 1.1M | 1.2M | 2.2M | 2.6M | 6.6M | 6.6M | 6.2M | 6.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 806M | 628.5M | 594.6M | 555.9M | 541.9M | 549M | 485.7M | 438.3M | 444.8M | 416M | 364.9M | 357.6M | 379.1M | 534.6M | 308.6M | 300.1M | 323.5M | 307.5M | 348.3M | 251.5M | 226.1M | 205.1M |
Income Tax Expense | 17.8M | 48.9M | 85.7M | 82.3M | 52M | 6.8M | 59.5M | 60.5M | 33.6M | -8.9M | 50.5M | 32.5M | 26.1M | -26.7M | 28.9M | 29.4M | -6.4M | 7.5M | -6.5M | 8M | 15.2M | -4.9M |
Shares Outstanding (Basic) | 101M | 100.5M | 99.5M | 99.4M | 99M | 99.7M | 100M | 101.1M | 100.8M | 99.8M | 98.4M | 97.9M | 97.6M | 97.1M | 96.3M | 95.8M | 95.6M | 95.3M | 94.9M | 94.7M | 94.6M | 94.2M |
Shares Outstanding (Diluted) | 104.2M | 103.4M | 102.5M | 102.5M | 101M | 102.5M | 102.9M | 104.3M | 103.9M | 103.6M | 102.3M | 101.1M | 100.2M | 97.1M | 100.8M | 99M | 95.6M | 97.6M | 94.9M | 97.7M | 97.7M | 98.2M |
EPS (Basic) | 1.43 | 1.97 | 1.54 | 2.11 | 1.09 | 0.08 | 1.03 | 1.28 | 0.64 | 0.43 | 1.50 | 0.85 | 0.98 | -0.79 | 0.92 | 0.72 | -0.18 | 0.15 | -0.08 | 0.24 | 0.45 | 0.34 |
EPS (Diluted) | 1.39 | 1.91 | 1.48 | 2.04 | 1.06 | 0.08 | 1 | 1.24 | 0.63 | 0.42 | 1.44 | 0.82 | 0.95 | -0.79 | 0.88 | 0.69 | -0.18 | 0.14 | -0.08 | 0.23 | 0.43 | 0.33 |
EBITDA | 189.9M | 193.3M | 235.4M | 299.5M | 166.8M | 31.3M | 181.7M | 191.3M | 155.2M | 111.5M | 205M | 122.2M | 126.7M | -97.2M | 123.4M | 103.1M | -17.2M | 27.3M | -4.2M | 39.9M | 66.3M | 36.1M |
EBIT | 165.1M | 186M | 227.9M | 291.8M | 159.5M | 23.7M | 174.6M | 184.8M | 147.9M | 105.3M | 199.3M | 116.7M | 121.6M | -102.2M | 119M | 99.1M | -21.1M | 24M | -7.2M | 37.1M | 63.7M | 33.6M |
Depreciation & Amortization | 24.8M | 7.3M | 7.5M | 7.7M | 7.3M | 7.6M | 7.1M | 6.5M | 7.3M | 6.2M | 5.7M | 5.5M | 5.1M | 5M | 4.4M | 4M | 3.9M | 3.3M | 3M | 2.8M | 2.6M | 2.5M |
Add to Watchlist
Select watchlists to add or remove NBIX